Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Colorectal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01348256
What this trial is testing

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaHepatic Metastasis
Clinica Universidad de Navarra, Universidad de Navarra 58
Early research (Phase 1)UnknownNCT05213195
What this trial is testing

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Refractory Metastatic Colorectal Cancer
Zhejiang University 38
Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Testing effectiveness (Phase 2)UnknownNCT03487939
What this trial is testing

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsDrug Therapy
China Medical University, China 30
Not applicableUnknownNCT02005913
What this trial is testing

A Novel Patent Platform of Detection of Circulating Tumor Cells to Early Detect Colorectal Cancer Recurrence

Who this might be right for
Colorectal Cancer (CRC)
National Taiwan University Hospital 600
Not applicableStudy completedNCT05300789
What this trial is testing

Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients

Who this might be right for
Peritoneal CarcinomatosisColon Cancer
Carlos Cerdán Santacruz 1,152
Testing effectiveness (Phase 2)Study completedNCT00165568
What this trial is testing

Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT04282590
What this trial is testing

Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Toray Industries, Inc
Testing effectiveness (Phase 2)Looking for participantsNCT05806931
What this trial is testing

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT01326000
What this trial is testing

RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 169
Not applicableLooking for participantsNCT06485609
What this trial is testing

Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer

Who this might be right for
Colon Cancer
Sun Yat-sen University 1,200
Large-scale testing (Phase 3)Looking for participantsNCT07702032
What this trial is testing

Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)

Who this might be right for
Left-sided Colorectal Cancer
Genmab 960
Not applicableActive Not RecruitingNCT06814093
What this trial is testing

Robotic Versus Laparoscopic Surgery for Middle and Low Rectal Cancer: a Target Trial Emulation

Who this might be right for
Rectal Cancer
Xu jianmin 2,702
Not applicableStudy completedNCT04880772
What this trial is testing

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

Who this might be right for
Cancer of ColonCancer of RectumLiver Metastases
East Lancashire Hospitals NHS Trust 42
Testing effectiveness (Phase 2)WithdrawnNCT04418895
What this trial is testing

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

Who this might be right for
Rectal Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Not applicableStudy completedNCT00969657
What this trial is testing

Validation of a Predictive Model After Complete Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Maastricht Radiation Oncology 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06790212
What this trial is testing

Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer
Sun Yat-sen University 168
Not applicableStudy completedNCT00741481
What this trial is testing

PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome.

Who this might be right for
Colorectal Cancer MetastaticEarly Response EvaluationFdg-PET
Jules Bordet Institute 40
Early research (Phase 1)Study completedNCT00611000
What this trial is testing

Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia

Who this might be right for
Colorectal Cancer
Rockefeller University 20
Next Page